GTC Biotherapeutics gtc-bio.com


Public list: Pharma Startups (4729) Cancer Therapeutics (1129)

GTC Biotherapeutics develops, supplies, and commercializes therapeutic proteins produced through transgenic animal technology. ATryn‚®, GTC‚'s recombinant human antithrombin, has been approved for use in the United States and Europe. ATryn is the first and only product produced in transgenic animals to be approved for therapeutic use anywhere in the world. In addition to ATryn, GTC is developing a portfolio of recombinant human plasma proteins with known therapeutic properties. These...Show all

GTC Biotherapeutics develops, supplies, and commercializes therapeutic proteins produced through transgenic animal technology. ATryn‚®, GTC‚'s recombinant human antithrombin, has been approved for use in the United States and Europe. ATryn ...Show all

Company (IPO / Went public)

Phone: 508-620-9700

Fax:

175 Crossing Boulevard
Framingham, 01702
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
GTC Biotherapeutics $44M Sep 6, 2005

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related GTC Biotherapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 17 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.